Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 30th December 2014
Summary The industry analysis specialist, has released its new report, “Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Vaginitis Infection Therapeutics market. The report identifies the key trends shaping and driving the global Vaginitis Infection Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Vaginitis Infection Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcare-medical/rvaginitis-therapeutics-pipeline-assessment-and-market-forecasts-135198 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Scope The report provides information on the key drivers and challenges of the Vaginitis Infection Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Vaginitis Infection Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Vaginitis Infection Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Vaginitis Infection Therapeutics market. - Analysis of key recent licensing and partnership agreements in Vaginitis Infection Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Vaginitis Infection Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Vaginitis Infection Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Vaginitis Infection Therapeutics market landscape? – Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Vaginitis Therapeutics - Introduction 2.1 Overview 2.1.1 Vaginitis Classification 2.2 Epidemiology 2.3 Etiology 2.4 Symptoms Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.5 Diagnosis 2.6 Pathophysiology 2.7 Treatment 2.8 GlobalData Pipeline Report Guide 3 Vaginitis Therapeutics - Market Characterization 3.1 Overview 3.2 Vaginitis Therapeutics Market Size (2006-2011) - Global 3.3 Vaginitis Therapeutics Market Forecast (2011-2019) - Global 3.4 Vaginitis Therapeutics Market - The US (2006-2011) 3.5 Vaginitis Therapeutics Market Forecast - The US (2011-2019) 3.6 Vaginitis Therapeutics Market - France (2006-2011) 3.7 Vaginitis Therapeutics Market Forecast - France (2011-2019) 3.8 Vaginitis Therapeutics Market - Germany (2006-2011) 3.9 Vaginitis Therapeutics Market Forecast - Germany (2011-2019) 3.10 Vaginitis Therapeutics Market - Italy (2006-2011) 3.11 Vaginitis Therapeutics Market Forecast - Italy (2011-2019) 3.12 Vaginitis Therapeutics Market - Spain (2006-2011) 3.13 Vaginitis Therapeutics Market Forecast - Spain (2011-2019) 3.14 Vaginitis Therapeutics Market - The UK (2006-2011) 3.15 Vaginitis Therapeutics Market Forecast - The UK (2011-2019) 3.16 Vaginitis Therapeutics Market - Japan (2006-2011) 3.17 Vaginitis Therapeutics Market Forecast - Japan (2011-2019) 3.18 Drivers and Barriers for the Vaginitis Therapeutics Market 3.18.1 Drivers for the Vaginitis Therapeutics Market 3.18.2 Barriers for the Vaginitis Therapeutics Market 3.19 Opportunity and Unmet Need 3.20 Key Takeaway 4 Vaginitis Therapeutics - Competitive Assessment 4.1 Overview 4.1.1 Strategic Competitor Assessment 4.2 Product Profile for the Major Marketed Products in the MI Therapeutics Market 4.2.1 Anti-Fungals 4.2.2 Boric acid 4.3 Key Takeaway 5 Vaginitis Therapeutics - Pipeline Assessment 5.1 Overview Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.2 Strategic Pipeline Assessment 5.3 Profile for Late Stage Molecules Under Clinical Development 5.3.1 Lcr35 5.3.2 Ketoconazole and Clindamycin Combination 5.3.3 Clindamycin phosphate and butoconazole nitrate combination 5.3.4 Trimo-San gel 5.4 Vaginitis Therapeutics Market - Clinical Pipeline by Mechanism of Action 5.4.1 Vaginitis Therapeutics - Phase III Clinical Pipeline 5.4.2 Vaginitis Therapeutics - Phase II Clinical Pipeline 5.4.3 Vaginitis Therapeutics - Phase I Clinical Pipeline 5.4.4 Vaginitis Therapeutics - Preclinical Pipeline 5.5 Key Takeaway 6 Vaginitis Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (the US, EU5 & Japan) 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Clinical Trials by Sponsors 6.5 Brief Profiles of Top 10 Companies Participating in Clinical Trials 7 Vaginitis Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Vaginitis Therapeutics - Future Players 8.1 Introduction 8.1.1 KV Pharmaceutical Company 8.1.2 Mission Pharmacal 8.1.3 Merck & Co., Inc. 8.1.4 Starpharma Holdings limited 8.1.5 Pfizer Inc. 8.1.6 Tabular Presentation Details of Other Companies in the Pipeline 9 Vaginitis Therapeutics - Licensing and Partnership Deals 10 Vaginitis Therapeutics - Appendix 10.1 Definitions 10.2 Acronyms 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography List Of Tables Table 1: Features of the Most Common Causes of Vaginitis Table 2: Treatments of the Most Common Causes of Vaginitis Table 3: Vaginitis Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 4: Vaginitis Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 5: Vaginitis Therapeutics Market, The US, Forecast ($m), 2006-2011 Table 6: Vaginitis Therapeutics Market, The US, Forecast ($m), 2011-2019 Table 7: Vaginitis Therapeutics Market, France, Revenue ($m), 2006-2011 Table 8: Vaginitis Therapeutics Market, France, Forecast ($m), 2011-2019 Table 9: Vaginitis Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 10: Vaginitis Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 11: Vaginitis Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 12: Vaginitis Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 13: Vaginitis Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 14: Vaginitis Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 15: Vaginitis Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 16: Vaginitis Therapeutics Market, The UK, Forecast ($m), 2011-2019 Table 17: Vaginitis Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 18: Vaginitis Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 19: Vaginitis Therapeutics - Phase III Clinical Pipeline, 2011 Table 20: Vaginitis Therapeutics - Phase II Clinical Pipeline, 2011 Table 21: Vaginitis Therapeutics - Phase I Clinical Pipeline, 2011 Table 22: Vaginitis Therapeutics - Preclinical Pipeline, 2011 Table 23: Vaginitis Therapeutics, Global, Clinical Trials, 2011 Table 24: Vaginitis Therapeutics, Global, Clinical Trials by Phase, 2011 Table 25: Vaginitis Therapeutics, Global, Clinical Trials by Status of Development, 2011 Table 26: Vaginitis Therapeutics, Global, Prominent Sponsors, 2011 Table 27: Vaginitis Therapeutics, Global, Top Ten Companies by Phase, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 28: KV Pharmaceutical Company - Pipeline Products Table 29 Merck & Co., Inc. - Pipeline Products Table 30 Starpharma Holding Limited - Pipeline Products Table 31: Other Companies in Pipeline, Therapeutics, 2011 Table 32: Therapeutics, Global, Deals, 2010
List Of Figures Figure 1: Diagnosis of Vaginitis Figure 2: Vaginitis Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 3: Vaginitis Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 4: Vaginitis Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 5: Vaginitis Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 6: Vaginitis Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 7: Vaginitis Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 8: Vaginitis Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 9: Vaginitis Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 10: Vaginitis Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 11: Vaginitis Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 12: Vaginitis Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 13: Vaginitis Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 14: Vaginitis Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 15: Vaginitis Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 16: Vaginitis Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 17: Vaginitis Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 18: Opportunity and Unmet Need in the Vaginitis (BV) Therapeutics Market, 2011 Figure 19: Opportunity and Unmet Need in the Vaginitis (Vaginal Candidiasis) Therapeutics Market, 2011 Figure 20: Opportunity and Unmet Need in the Vaginitis (Trichomoniasis) Therapeutics Market, 2011 Figure 21: Strategic Competitor Assessment, 2011 Figure 22: Technology Trends Analytics Frame Work, 2011 Figure 23: Technology Trends Analytics Frame Work - Description, 2011 Figure 24: Vaginitis Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 25: Vaginitis Therapeutics Market - Clinical Pipeline by Phase of Development, 2011 Figure 26: Vaginitis Therapeutics, Global, Clinical Trials by Country, 2011 Figure 27: Vaginitis Therapeutics, Global, Clinical Trials by Phase (%), 2011 Figure 28: Vaginitis Therapeutics, Global, Clinical Trials by Status of Development (%), 2011 Figure 29: Vaginitis Therapeutics, Global, Overall Sponsors (%), 2011 Figure 30: Vaginitis Therapeutics, Global, Prominent Sponsors (%), 2011 Figure 31: Vaginitis Therapeutics, Global, Top Ten Companies by Phase, 2011 Figure 32: Vaginitis Therapeutics Market, Drivers and Barriers, 2011 Figure 33: Implications for Future Market Competition in the Vaginitis Therapeutics Market, 2011 Figure 34: Vaginitis Infection Therapeutics Market - Clinical Pipeline by Company, 2011 Figure 35: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
to 2019 Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Athlete’s Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019 Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-vaginitistherapeutics-pipeline-assessment-and-market-forecasts-135198
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/